SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-082999
Filing Date
2022-07-27
Accepted
2022-07-27 09:15:36
Documents
48
Period of Report
2022-07-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221840d1_8k.htm   iXBRL 8-K 28336
2 EXHIBIT 99.1 tm2221840d1_ex99-1.htm EX-99.1 47136
6 GRAPHIC tm2221840d1_ex99-1img001.jpg GRAPHIC 1000449
7 GRAPHIC tm2221840d1_ex99-1img002.jpg GRAPHIC 561488
8 GRAPHIC tm2221840d1_ex99-1img003.jpg GRAPHIC 272251
9 GRAPHIC tm2221840d1_ex99-1img004.jpg GRAPHIC 279605
10 GRAPHIC tm2221840d1_ex99-1img005.jpg GRAPHIC 379290
11 GRAPHIC tm2221840d1_ex99-1img006.jpg GRAPHIC 380825
12 GRAPHIC tm2221840d1_ex99-1img007.jpg GRAPHIC 329002
13 GRAPHIC tm2221840d1_ex99-1img008.jpg GRAPHIC 387244
14 GRAPHIC tm2221840d1_ex99-1img009.jpg GRAPHIC 123668
15 GRAPHIC tm2221840d1_ex99-1img010.jpg GRAPHIC 296679
16 GRAPHIC tm2221840d1_ex99-1img011.jpg GRAPHIC 160196
17 GRAPHIC tm2221840d1_ex99-1img012.jpg GRAPHIC 360816
18 GRAPHIC tm2221840d1_ex99-1img013.jpg GRAPHIC 118047
19 GRAPHIC tm2221840d1_ex99-1img014.jpg GRAPHIC 546869
20 GRAPHIC tm2221840d1_ex99-1img015.jpg GRAPHIC 504267
21 GRAPHIC tm2221840d1_ex99-1img016.jpg GRAPHIC 382788
22 GRAPHIC tm2221840d1_ex99-1img017.jpg GRAPHIC 136084
23 GRAPHIC tm2221840d1_ex99-1img018.jpg GRAPHIC 517268
24 GRAPHIC tm2221840d1_ex99-1img019.jpg GRAPHIC 348262
25 GRAPHIC tm2221840d1_ex99-1img020.jpg GRAPHIC 325957
26 GRAPHIC tm2221840d1_ex99-1img021.jpg GRAPHIC 615653
27 GRAPHIC tm2221840d1_ex99-1img022.jpg GRAPHIC 133271
28 GRAPHIC tm2221840d1_ex99-1img023.jpg GRAPHIC 401773
29 GRAPHIC tm2221840d1_ex99-1img024.jpg GRAPHIC 435537
30 GRAPHIC tm2221840d1_ex99-1img025.jpg GRAPHIC 135593
31 GRAPHIC tm2221840d1_ex99-1img026.jpg GRAPHIC 818640
32 GRAPHIC tm2221840d1_ex99-1img027.jpg GRAPHIC 138635
33 GRAPHIC tm2221840d1_ex99-1img028.jpg GRAPHIC 404605
34 GRAPHIC tm2221840d1_ex99-1img029.jpg GRAPHIC 209575
35 GRAPHIC tm2221840d1_ex99-1img030.jpg GRAPHIC 245037
36 GRAPHIC tm2221840d1_ex99-1img031.jpg GRAPHIC 410429
37 GRAPHIC tm2221840d1_ex99-1img032.jpg GRAPHIC 412607
38 GRAPHIC tm2221840d1_ex99-1img033.jpg GRAPHIC 222143
39 GRAPHIC tm2221840d1_ex99-1img034.jpg GRAPHIC 417657
40 GRAPHIC tm2221840d1_ex99-1img035.jpg GRAPHIC 78957
  Complete submission text file 0001104659-22-082999.txt   17341783

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vyne-20220727.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vyne-20220727_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vyne-20220727_pre.xml EX-101.PRE 22613
42 EXTRACTED XBRL INSTANCE DOCUMENT tm2221840d1_8k_htm.xml XML 3708
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 221109163
SIC: 2834 Pharmaceutical Preparations